Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

2.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

3.

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

4.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

5.

Study: For predicting breast cancer, AI performs better than traditional risk models.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot